MENU

Why WAM Capital Limited owns shares of Primary Health Care Limited

WAM Capital Limited (ASX: WAM) is one of the biggest listed investment companies (LICs) on the ASX. It’s also one of the highest-performing LICs, reporting in its half-year report that it outperformed its benchmark for the six months to 31 December 2017.

Investment managers that have a long-term records of outperforming the market are worth monitoring in my opinion. If there’s a share that the manager thinks could be a winner then it could be a winner for our portfolios as well.

Primary Health Care Limited (ASX: PRY) is one of Australia’s largest healthcare companies with a market capitalisation close to $2 billion.

The business says it is committed to providing affordable, accessible and comprehensive healthcare for all Australians. It does this by offering pathology, medical centres, diagnostic imaging and IVF services, all at a low cost.

In FY17 the company didn’t report a great set of financials with both underlying and reported net profit after tax (NPAT) decreasing. The one good part was that revenue grew a little.

I believe that the WAM Capital team are excited by Primary Health Care because the government has given clarity on funding.

There will be a progressive restoration of the Medicare indexation for GPs, specialists and some imaging modalities. This is expected to deliver around $3.5 million in annual revenue growth in FY19.

Primary is also likely to participate in 12 ‘Health Care Homes’ trials and expects more positive short-term policy setting.

Foolish takeaway

Primary is currently trading at 19x FY18’s estimated earnings with a grossed-up dividend yield of 4.3%. Primary is an interesting and defensive choice for WAM Capital, it’s not the type of share I’d expect the team to choose, but they have a knack for picking shares at the right time.

If Primary isn’t your type of stock, you’d probably prefer one of these hot stocks.

Top 3 ASX Blue Chips To Buy In 2018

For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked..

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool’s in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool’s Top 3 Blue Chip Stocks for 2018."

Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.

The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand – and how quickly the share prices of these companies moves – we may be forced to remove this report.

Click here to claim your free report.

Motley Fool contributor Tristan Harrison owns shares of WAM Capital Limited. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The 5 mining stocks we’re recommending in 2019…

For decades, Australian mining companies have minted money for individual investors like you and me. But if you believe the pundits and talking heads on TV, those days are long gone. Finito! Behind us forever…

We say nothing could be further from the truth. To earn the really massive returns, you’ve got to fish where others aren’t fishing—and the mining sector could be primed for a resurgence. That’s why top Motley Fool analysts just revealed their exciting new research on 5 ASX miners they believe could help you profit in 2019 and beyond…

Including:

The best way we see to play the global zinc shortage… Our #1 favourite large-cap miner (hint: it’s not BHP)… one early-stage gold miner we think could hit the motherlode… Plus two more surprising companies you probably haven’t heard of yet!

For free access to our brand-new research, simply click here or the link below. But be warned, this research is available free for a limited time only, and we reserve the right to withdraw it at any time.

Click here for your FREE report!